Medical News

RSS

EpiCept to receive $0.97M in public offering

EpiCept Corporation announced today that it has entered into a definitive agreement with a single life science focused institutional investor for the purchase of 1,065 shares of its new Series B 0% Convertible Preferred Stock at $1,000 per share, which are convertible into an aggregate of approximately 6.3 million shares of its common stock, and five-year warrants to purchase up to approximately 3.1 million shares of its common stock at an exercise price of $0.17 per share that are immediately exercisable.

29 Mar 2012

CHVI announces new member - Healthper

The nonprofit Center for Health Value Innovation (CHVI) announced today that Healthper, Inc., a social game-based health engagement and achievement platform, has joined as a member.

29 Mar 2012

Justices consider whether Medicaid expansion is constitutional or coercive

During the Supreme Court's last hour of a marthon series of oral arguments, some justices indicated strong disagreement with the challenge brought by 26 states to the health law's Medicaid expansion.

29 Mar 2012

Researchers profile genetic changes in cancer with drug sensitivity

In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 March 2012.

29 Mar 2012

Paramedics are probably right when they suspect strokes

If a paramedic suspects a patient is having a stroke, the paramedic is probably right, a Loyola University Medical Center study has found.

29 Mar 2012

Smiths Medical initiates voluntary market withdrawal of CoZmonitor Blood Glucose Monitoring Systems

Smiths Medical, a leading global medical device manufacturer, announced today that it is initiating a U.S. and Canada, voluntary market withdrawal of CoZmonitor Blood Glucose Monitoring Systems. The FDA has been apprised of this action.

29 Mar 2012

Scientists explore number of strategies to prevent anesthesia-induced injury in infants

Recent clinical studies have shown that general anesthesia can be harmful to infants, presenting a dilemma for both doctors and parents. But new research at Wake Forest Baptist Medical Center may point the way to treatment options that protect very young children against the adverse effects of anesthesia.

29 Mar 2012

EU's Safety Evaluation Ultimately Replacing Animal Testing initiative tests Roche's xCELLigence system

Roche's xCELLigence RTCA System is being used in the European Union's SEURAT (Safety Evaluation Ultimately Replacing Animal Testing) initiative to run five years from 2011 to 2016.

From Roche Sequencing and Life Science 29 Mar 2012

Wisconsin Veterans home receives $800,000 from VA

The Department of Veterans Affairs is awarding nearly $800,000 to renovate the heating, ventilation and air conditions systems at Fairchild and Shermanske halls at the Wisconsin Veterans home in Union Grove.

29 Mar 2012

NEJM publishes results from Amgen's brodalumab Phase 2 trial on plaque psoriasis

Amgen announced today that results from a Phase 2 trial evaluating the safety and efficacy of brodalumab in 198 patients with moderate to severe plaque psoriasis were published in the New England Journal of Medicine.

29 Mar 2012

MESO-1 device can help in diagnosis and treatment of cancer

A new device designed to more effectively produce DNA samples for genetic testing from slide-mounted tissue samples is better equipped than most models on the market to help in the diagnosis and treatment of cancer.

29 Mar 2012

Nature journal publishes first volume of Cancer Cell Line Encyclopedia

The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such "personalized" drugs can be developed, more knowledge is needed about specific genomic alterations in cancers and their sensitivity to potential therapeutic agents.

29 Mar 2012

Single-port laparoscopic appendectomy performed at Valley Presbyterian Hospital

Surgeons at Valley Presbyterian Hospital (VPH) recently performed the hospital's first-ever single-port laparoscopic appendectomy, a minimally invasive surgical procedure for removing an infected appendix, which reduces scarring and healing time because it requires only one incision, Gustavo Valdespino, VPH president and CEO, announced today.

29 Mar 2012

Rates of cancer diagnoses and deaths continue to decline in the U.S.

A report from the nation's leading cancer organizations shows rates of death in the United States from all cancers for men and women continued to decline between 2004 and 2008. The findings come from the latest Annual Report to the Nation on the Status of Cancer.

29 Mar 2012

Interleukin, U-M School of Dentistry complete enrollment in PST Genetic Test study

The University of Michigan School of Dentistry and Interleukin Genetics, Inc. announced today the completion of patient enrollment for a landmark clinical study using Interleukin's PST Genetic Test to determine if dental patients can be risk-stratified to guide frequency of preventive dental visits and reduce the adverse outcomes of periodontal disease progression, such as tooth loss.

29 Mar 2012

MiR-375 regulates IL-13-induced changes in allergic diseases

Researchers have taken a critical step in understanding how allergic reactions occur after identifying a genetic signature for regulation of a key immune hormone, interleukin (IL-13).

29 Mar 2012

Strand Diagnostics to receive $30 million in funding from NantWorks

Strand Diagnostics, LLC, maker of the know error system, and NantWorks, LLC announced that they have entered into an agreement whereby Strand will receive up to $30 million in funding from NantWorks, LLC over the next 3 years.

29 Mar 2012

Spherix 2011 net loss decreases to $3.5 million

Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies – today reported financial results for the year ended December 31, 2011, and recent and upcoming business highlights.

29 Mar 2012

Study sheds light on the impact that zero-calorie beverages may have on health

Are diet sodas good or bad for you? The jury is still out, but a new study sheds light on the impact that zero-calorie beverages may have on health, especially in the context of a person's overall dietary habits.

29 Mar 2012

Malaria funding has helped prevent nearly 1M child deaths over past decade, study finds

The results of a study published in Malaria Journal "suggest that funding for malaria prevention in Africa over the past decade has had a substantial impact on decreasing child deaths due to malaria," according to the study's abstract.

29 Mar 2012